Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Total Equity

Arcus Biosciences Inc Total Equity Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Total Equity from 2017 to 2018.
  • Arcus Biosciences Inc Total Equity for the quarter ending December 12, 2018 was $235m a -13.47% decrease of -32m year over year
  • Arcus Biosciences Inc Total Equity for the last 12 months ending December 12, 2018 was $235m a -13.47% decrease of -32m year over year
  • Arcus Biosciences Inc Annual Total Equity for 2018 was $235m a 34.51% increase of 81m from 2017
  • Arcus Biosciences Inc Annual Total Equity for 2017 was $154m a 35.36% increase of 54m from 2016
  • Arcus Biosciences Inc Annual Total Equity for 2016 was $99m
Other Balance Sheet Metrics:
  • Arcus Biosciences Inc Total Assets for the quarter ending December 12, 2018 was $275m a -11.08% decrease of -30m year over year
  • Arcus Biosciences Inc Other Liabilities for the quarter ending December 12, 2018 was $23m a -6.50% decrease of -1m year over year
View Chart On Koyfin

Quarterly RCUS Total Equity Data

12/2018$235m
09/2018$245m
06/2018$255m
03/2018$267m
12/2017$154m
03/2017$99m

Annual RCUS Total Equity Data

2018$235m
2017$154m
2016$99m